Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy and Autotransplantation for Anaplastic Oligodendroglioma
NCT00003101Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 1997
- Primary completion
- Jan 2002
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of lomustine, procarbazine, vincristine, thiotepa, busulfan in anaplastic oligodendroglioma (AO), oligoastrocytoma, sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 1997; status: completed.
02
Drugs
lomustineprocarbazinevincristinethiotepabusulfan
03
Conditions
anaplastic oligodendroglioma (AO)oligoastrocytoma
Beyond the preview
Go deeper on NCT00003101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003101.